[Congressional Record (Bound Edition), Volume 163 (2017), Part 9]
[Senate]
[Page 12446]
[From the U.S. Government Publishing Office, www.gpo.gov]




           FDA REAUTHORIZATION ACT OF 2017--MOTION TO PROCEED

  Mr. McCONNELL. Mr. President, I move to proceed to Calendar No. 174, 
H.R. 2430.
  The PRESIDING OFFICER. The clerk will report the motion.
  The legislative clerk read as follows:

       Motion to proceed to Calendar No. 174, H.R. 2430, a bill to 
     amend the Federal Food, Drug, and Cosmetic Act to revise and 
     extend the user-fee programs for prescription drugs, medical 
     devices, generic drugs, and biosimilar biological products, 
     and for other purposes.


                             Cloture Motion

  Mr. McCONNELL. Mr. President, I send a cloture motion to the desk.
  The PRESIDING OFFICER. The cloture motion having been presented under 
rule XXII, the Chair directs the clerk to read the motion.
  The legislative clerk read as follows:

                             Cloture Motion

       We, the undersigned Senators, in accordance with the 
     provisions of rule XXII of the Standing Rules of the Senate, 
     do hereby move to bring to a close debate on the motion to 
     proceed to calendar No. 174, H.R. 2430, an act to amend the 
     Federal Food, Drug, and Cosmetic Act to revise and extend the 
     user-fee programs for prescription drugs, medical devices, 
     generic drugs, and biosimilar biological products, and for 
     other purposes.
         Mitch McConnell, Steve Daines, Mike Crapo, James M. 
           Inhofe, Lamar Alexander, Pat Roberts, Thom Tillis, 
           Orrin G. Hatch, John Cornyn, Cory Gardner, Roy Blunt, 
           James E. Risch, Roger F. Wicker, Tim Scott, John Thune, 
           Mike Rounds, John Hoeven.

  Mr. McCONNELL. Mr. President, I ask unanimous consent that the 
mandatory quorum call be waived with respect to the cloture motion.
  The PRESIDING OFFICER. Without objection, it is so ordered.

                          ____________________